This announcement is a separate document:
黑龙江珍宝岛药业股份有限公司2024年第一季度报告
Report for the first quarter of 2024 of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Latest
06:33
The offshore renminbi (CNH) against the US dollar reported 7.2629 yuan at 05:59 Beijing time, an increase of 786 points compared to last Friday's New York closing, with overall trading during the day between the Range of 7.3387 and 7.2601 yuan.
06:30
The USA Senate Intelligence Committee has approved John Ratcliffe to serve as CIA Director.
06:26
USA President Trump and USA Vice President Vance arrived at the First Capital Sports Arena.
Ontology+2.63%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.